Skip to content
10-Q

Quarterly Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-19-000888

← back to feed
Filed
May 15, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 10, 2019 8.04M sh
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$7.25K
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$10.68K
Long Term Debt Q1 2019 · Mar 31, 2019 $3.96K
Long Term Debt Q1 2019 · Dec 31, 2018 $3.96K
Stockholders Equity Q1 2019 · Mar 31, 2019 −$202.51K
Stockholders Equity Q1 2019 · Dec 31, 2018 −$185.32K
Stockholders Equity Q1 2019 · Mar 31, 2018 −$141.68K
Stockholders Equity Q1 2019 · Dec 31, 2017 −$129.54K
Current Liabilities Q1 2019 · Mar 31, 2019 $198.55K
Current Liabilities Q1 2019 · Dec 31, 2018 $187.36K
Total Liabilities Q1 2019 · Mar 31, 2019 $202.51K
Total Liabilities Q1 2019 · Dec 31, 2018 $191.32K
Sga Expense Q1 2019 · Mar 31, 2019 $382
Net Income Q1 2019 · Mar 31, 2019 −$447.1K
Net Income Q1 2019 · Mar 31, 2018 −$12.13K
Operating Income Q1 2019 · Mar 31, 2019 −$440.92K
Operating Income restated Q1 2019 · Mar 31, 2018 −$1.49K
Current Assets Q1 2019 · Dec 31, 2018 $6K
Total Assets Q1 2019 · Dec 31, 2018 $6K
Cash And Equivalents Q1 2019 · Mar 31, 2018 $4.77K
Cash And Equivalents Q1 2019 · Dec 31, 2017 $1.49K